Dr. El Chaer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
University of Virginia Health System
PO Box 800716
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-244-7526- Is this information wrong?
Summary
- Dr. Firas El Chaer is an oncologist and hematologist in Charlottesville, VA and is affiliated with the University of Virginia Medical Center. He received his medical degree from University of Balamand Faculty of Medicine and has been in practice 5 years. He also speaks multiple languages, including English, Arabic and French. He is experienced in myeloproliferative disorders, aplastic anemia, acute leukemia, myelodysplastic syndromes, bone marrow failure syndromes, chronic myeloid leukemia and general internal medicine.
Education & Training
- University of MarylandFellowship, Hematology and Medical Oncology, 2016 - 2019
- Baylor College of MedicineFellowship, Infectious Disease, 2014 - 2016
- University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 2014 - 2016
- Hackensack University Medical Center/Englewood Hospital and Medical CenterResidency, Internal Medicine, 2011 - 2014
- University of Balamand Faculty of MedicineClass of 2011
Certifications & Licensure
- VA State Medical License 2018 - 2024
- NJ State Medical License 2012 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Internal Medicine Residency Inpatient Attending of the Year University of Virginia, 2022
- Department of Medicine Excellence in Research Award University of Virginia, 2021
- Fellow Teaching Award University of Maryland Medical Center, 2018
- Join now to see all
Clinical Trials
- A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001) Start of enrollment: 2022 Nov 29
- Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS Start of enrollment: 2020 Aug 19
Publications & Presentations
PubMed
- 11 citationsHow I treat AML incorporating the updated classifications and guidelines.Firas El Chaer, Christopher S Hourigan, Amer M Zeidan> ;Blood. 2023 Jun 8
- Post-Hematopoietic Cell Transplantation Relapsed Acute Lymphoblastic Leukemia: Current Challenges and Future Directions.Indumathy Varadarajan, Eric Pierce, Lisa Scheuing, Amy Morris, Firas El Chaer, Michael Keng> ;Oncotargets and Therapy. 2023 Jan 1
- 19 citationsHow I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies.Firas El Chaer, Jeffery J Auletta, Roy F Chemaly> ;Blood. 2022 Aug 18
- Join now to see all
Press Mentions
- How Targeted Therapies are Affecting the Cancer Care Team: A Conversation With Dr. Firas El ChaerFebruary 25th, 2020
- The role of post-transplant maintenance therapy in AMLMay 25th, 2022
- Advances & unmet needs in APLMay 25th, 2022
Committees
- Member, Data and Safety Monitoring Committee 2021 - Present
- Member, Diversity, Equity and Inclusion (DEI) Committee 2021 - Present
- Member, Protocol Review Committee 2020 - Present
- Member, Commission on Cancer 2020 - Present
- Member, Fellowship Program Evaluation Committee 2020 - Present
- Member, Fellowship Selection Committee 2020 - Present
Professional Memberships
- Member
- The American Society for Transplantation and Cellular TherapyMember
Other Languages
- Arabic, French
Hospital Affiliations
- University of Virginia Medical CenterCharlottesville, Virginia
External Links
- UVA Healthhttps://uvahealth.com/findadoctor/profile/firas-el-chaer
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: